Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.17 USD | 0.00% | -1.21% | -28.01% |
02-06 | Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating | MT |
02-01 | Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating | MT |
Sales 2024 * | 120M 9.58B | Sales 2025 * | 136M 10.9B | Capitalization | 373M 29.82B |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.28B | Net income 2025 * | 5M 400M | EV / Sales 2024 * | 3.11 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
-22.4
x | P/E ratio 2025 * |
65.4
x | Employees | 376 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.25% |
Latest transcript on Surmodics, Inc.
1 week | -1.21% | ||
Current month | -10.80% | ||
1 month | -7.23% | ||
3 months | -23.81% | ||
6 months | -8.08% | ||
Current year | -28.01% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Maharaj
CEO | Chief Executive Officer | 61 | 26/12/10 |
Timothy Arens
DFI | Director of Finance/CFO | 57 | 31/01/07 |
Teri L. Sides
PRN | Corporate Officer/Principal | 55 | 31/10/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Kalich
BRD | Director/Board Member | 77 | 16/02/14 |
Susan Knight
CHM | Chairman | 70 | 28/01/08 |
José Bedoya
BRD | Director/Board Member | 68 | 31/12/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 27 M€ | -5.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 26.17 | 0.00% | 22,671 |
25/04/24 | 26.17 | +0.38% | 31,837 |
24/04/24 | 26.07 | -3.16% | 62,844 |
23/04/24 | 26.92 | +6.03% | 52,914 |
22/04/24 | 25.39 | -4.15% | 116,361 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.01% | 373M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- SRDX Stock